A screening study of HER2 expression for biliary tract cancer

A screening study of HER2 expression for biliary tract cancer - HERB preSCR

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000036697

Enrollment

200

Registered

2019-05-09

Start date

2019-05-09

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

biliary tract cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Histologically proven adenocarcinoma or adenosquamous carcinoma 2. Unresectable or recurrent biliary tract cancer by chest computed tomography (CT) and enhanced abdominal/pelvic CT or magnetic resonance imaging (MRI). 3. Age, 20 years or elder. 4. Written informed consent.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
HER2 expression	—

Countries

Japan

Contacts

Public ContactAkihiro Ohba

National Cancer Center Hospital Department of Hepatobiliary and Pancreatic Oncology

aohba@ncc.go.jp03-3542-2511

Outcome results